Tissue microarray technology in the routine assessment of HER2 status in invasive breast cancer

Histopathology. 2009 Jun;54(7):901. doi: 10.1111/j.1365-2559.2009.03304.x.
No abstract available

Publication types

  • Comparative Study
  • Evaluation Study
  • Letter
  • Comment

MeSH terms

  • Breast Neoplasms / genetics
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / pathology
  • Female
  • Genes, erbB-2
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization, Fluorescence
  • Receptor, ErbB-2 / metabolism*
  • Tissue Array Analysis / methods*

Substances

  • ERBB2 protein, human
  • Receptor, ErbB-2